State of Wisconsin Investment Board’s Soleno Therapeutics SLNO Stock Holding History

State of Wisconsin Investment Board’s Portfolio SLNO Stock Details SLNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-90,907	Closed	-$3.04M	–	2647
2026 Q1	$3.04M	Buy	90,907 +18,425	+25%	+$722K	0.01%	1194
2025 Q4	$3.36M	Buy	72,482 +32,290	+80%	+$1.77M	0.01%	1167
2025 Q3	$2.72M	Buy	40,192 +26,299	+189%	+$1.95M	0.01%	1239
2025 Q2	$1.16M	Sell	13,893 -2,608	-16%	-$195K	﹤0.01%	1516
2025 Q1	$1.18M	Sell	16,501 -371	-2%	-$18.1K	﹤0.01%	1424
2024 Q4	$758K	Buy	16,872 +3,457	+26%	+$179K	﹤0.01%	1625
2024 Q3	$677K	Buy	13,415 +2,808	+26%	+$134K	﹤0.01%	1728
2024 Q2	$433K	Sell	10,607 -519	-5%	-$22K	﹤0.01%	1894
2024 Q1	$476K	Buy	11,126 +1,630	+17%	+$73.7K	﹤0.01%	1781
2023 Q4	$382K	Buy	+9,496	New	+$270K	﹤0.01%	1907

State of Wisconsin Investment Board's SLNO Position: Q2 2026 in Review

State of Wisconsin Investment Board sold out of Soleno Therapeutics (SLNO) in Q2 2026, closing a stake of 90,907 shares — an estimated $3.04M sold.

State of Wisconsin Investment Board first reported a position in SLNO in Q4 2023 and held it in 10 quarters. The position peaked at $3.36M in Q4 2025. 0 funds tracked by Wall St. Rank hold SLNO as of Q2 2026.

State of Wisconsin Investment Board reported no remaining Soleno Therapeutics position as of Q2 2026 after selling out during the quarter.
State of Wisconsin Investment Board sold 90,907 Soleno Therapeutics shares in Q2 2026, an estimated $3.04M.
State of Wisconsin Investment Board first reported a position in Soleno Therapeutics in Q4 2023 and held it in 10 quarters.
State of Wisconsin Investment Board's Soleno Therapeutics position peaked at $3.36M in Q4 2025.
0 funds tracked by Wall St. Rank held Soleno Therapeutics as of Q2 2026.

Based on State of Wisconsin Investment Board's 13F filing for Q2 2026, filed 14 Aug 2026.